Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Thumb arthritis sufferers: could a double injection be the key to less pain?

NCT ID NCT03431584

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether a mix of two common injections—cortisone and hyaluronic acid—works better than cortisone alone for thumb arthritis pain. 150 adults with moderate to severe pain took part. The goal was to see if the combination provides more relief.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 4

Runs after approval, following long-term safety and how well the treatment works in everyday use.

Participants

150 people

The number who actually took part.

Started

May 2018

Finished

Dec 2021

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

40 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults, ≥ 40 years * Pain located at the root of the thumb (near the wrist) and awakened by direct pressure and movement * Pain resistant to well-conducted medical treatment, with analgesics, NSAIDs, icing with pain (analog visual scale) ≥ 4 for more than 3 months * Radiological findings (kapandji face + profile incidence) typical of rhizarthrosis, stage II or III of Eaton and Litter, with at least 2 of the following 5 radiological elements observed on the trapeziometacarpal joint: * marginal osteophyte * pinching of the joint space * sclerosis of the subchondral space * subchondral kyst * absence of osteopenia * Patient with the ability to understand the protocol and signed informed consent * Patient receiving social security Exclusion Criteria: * Known allergy to any of the products (corticosteroids or hyaluronic acid) including its excipients (methyl parahydroxybenzoate, propyl parahydroxybenzoate, benzyl alcohol) * Change of analgesic treatment within 4 weeks before inclusion. * Patients with symptomatic bilateral rhizarthrosis * Scaphoid-trapezial arthrosis * Local or general infection * Severe coagulation disorders, ongoing anticoagulant therapy * severe and / or uncontrolled hypertension * Earlier local surgery * Associated inflammatory rheumatism * Tendinopathy of De Quervain, thumb to jump associated * Infiltrations earlier than 6 months * Diabetes imbalanced * Live vaccines * Severe water and / or sodium retention (hypernatremia), particularly in cases of heart failure, decompensated liver failure (edema and ascites failure) * Pregnant or lactating women * Immunocompromised or hemodialysis patients * Patients under guardianship, trusteeship, or deprived of liberty * Patients participating in another clinical research protocol involving a drug or medical device * Patients unable to follow the protocol, according to the judgment of the investigator

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Rhizarthrosis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CH Cholet

    Cholet, 49300, France

  • CH Le Mans

    Le Mans, 72037, France

  • CHD Vendée

    La Roche-sur-Yon, 85925, France

  • CHU Nantes

    Nantes, 44000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.